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The measles virus (MV) P gene encodes three proteins: the P protein and two nonstructural proteins, C and V. Because
the functions of both the C and V protein are unknown, we used MV C (C2) and V (V2) deletion recombinants generated by
the MV reverse genetics system (F. Radecke, P. Spielhofer, H. Schnieder, K. Kaelin, M. Huber, C. Dotsch, G. Christiansen, and
M. A. Billeter 1995. EMBO J. 14, 5773–5784). Compared to parental vaccine strain, Edmonston (Ed) MV, both had normal
growth and cytopathic effects in Vero cells and showed similar growth kinetics in human neuroblastoma SK-N-MC cells and
in primary mouse neurons expressing the MV receptor, CD46. However, in vivo, using YAC-CD46 transgenic mice as a model
for MV induced CNS disease (M. B. A. Oldstone, H. Lewicki, D. Thomas, A. Tishon, S. Dales, J. Patterson, M. Manchester, D.
Homann, D. Naniche, and A. Holz 1999. Cell 98, 629–640), C2 and V2 viruses differed markedly from wt Ed(V1C1) virus.
Newborn mice inoculated with as little as 103 PFU of Ed strain became ill and died after 10–15 days. In contrast, those
inoculated with 103 or 104 PFU of MV C2 or MV V2 showed significantly fewer and milder clinical symptoms and had a lower
mortality. A total of 105 PFU V2 virus were required to kill most YAC-CD46 mice, and less than half (44%) were killed with a
corresponding dose of MV C2. Immunohistochemical staining for MV antigens showed similar extents of spread for MV C2
and MV Ed but restricted spread for MV V2 throughout the brain. Viral load and transcription were markedly reduced for V2
but not for C2. Multiple cytokines and chemokines were equivalently upregulated for all three viruses. Therefore, MV C and
V proteins encode virulence functions in vivo and likely operate via separate mechanisms. © 2000 Academic PressINTRODUCTION
Measles virus (MV), the prototypic Morbillivirus, is en-
coded by a single genomic RNA of negative sense with
six genes that generate eight known proteins (Griffin and
Bellini, 1996). The functions of the matrix (M), fusion (F),
and hemagglutinin (HA) genes involved in viral entry into
cells, assembly, and exit are partially understood. In
addition, three gene products are required for replica-
tion: the polymerase (L), nucleocapsid (N), and phospho-
protein (P). All MV proteins are derived from single cis-
trons except for P. The P gene encodes a heavily phos-
phorylated protein of 60 kDa, which, in association with
L, is required for transcription and replication of the
ribonucleoprotein (RNP) complex (Griffin and Bellini,
1996). In addition, the P cistron encodes two other pro-
teins, C and V, whose functions are not known but ap-
pear not to be required for replication in cultured cells
(Radecke and Billeter, 1996; Schneider et al., 1997).
The C protein (21 kDa) is translated from a second
open reading frame (ORF) (11 relative to P ORF) initiated
from the second AUG located19 nucleotides (nt) down
stream of the P AUG, thus giving rise to a unique amino
acid (aa) sequence (Bellini et al., 1985). The C proteins
are related amongst the Morbilliviruses and are encoded
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80by all Paramyxoviruses; however, aa sequences are not
conserved within this group. The C protein of Sendai
virus (SeV) is thought to downregulate viral transcription
by a promoter-specific mechanism (Cadd et al., 1996;
Tapparel et al., 1997) and is found in small quantities in
nucleocapsids and virions (Portner et al., 1986). A recom-
binant SeV silenced of C and C9 but not the shorter Y1
and Y2 ORFs was rescued but was greatly attenuated in
vitro and almost completely incapable of replicating in
vivo (Kurotani et al., 1998). Furthermore a recombinant
SeV devoid of all C ORFs was recovered but highly
restricted for growth in vitro, clearly showing that the C
proteins are not absolutely essential for replication (Ku-
rotani et al., 1998). In contrast, when MV C protein was
silenced, the virus grew as well as the wild type in cell
culture (Radecke and Billeter, 1996).
Expression of the V protein is driven by transcription
and translation of the P gene using the P AUG and ORF.
Approximately half of the transcripts undergo an editing
process whereby a nontemplated guanosine (G) is co-
transcriptionally inserted at P mRNA position 751, leading
to an alternative C terminus after aa 231(Cattaneo et al.,
1988). Sixty-eight unique aa containing a high proportion
of cysteine replace the C terminus of P, giving the V
protein a length of 299 aa rather than 507 (Cattaneo et
al., 1988). V proteins are not unique amongst the Morbil-
liviruses as they are encoded by all members of subfam-
ily Paramyxovirinae with the exception of human parain-
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Genomic organization of wild-type MV Ed and MVs lacking expression of
the C (MV C2) or V (MV V2) proteins used in this study.
staining were similar in matched sections of the brain (panels 3, 6, 9, and 12
105 PFU (data not shown).
81MEASLES VIRUS PROTEINS AS VIRULENCE FACTORS IN VIVOfluenza viruses 1 and 3 (Lamb and Kolakofsky, 1996).
Although different strategies for generation of V proteins
are utilized by different viruses within the group, the
C-terminal cysteine-rich domain of the V protein is highly
conserved, whereas the entire P protein is not (Lamb and
Kolakofsky, 1996). The seven cysteine residues are ex-
actly conserved within all of the known V proteins, and
show a remote similarity to zinc fingers. Zinc binding has
been demonstrated for MV V (Liston and Briedis, 1994)
and SeV V (Paterson et al., 1995). Other aa are exactly
conserved with the most notable stretch being an HRRE
motif immediately distal to the nontemplated G insertion
site. This degree of conservation suggests that the V
proteins have an important function in the life cycle of
these viruses. MV V protein is not associated with either
MV virions or RNP complexes but rather is found dif-
fusely distributed thoughout infected cells (Wardrop and
Briedis, 1991). The N-terminal portion of V binds to unin-
corporated N protein and may down modulate RNA syn-
thesis (Curran et al., 1991; Horikami et al., 1996; Tober et
l., 1998). Studies of V function have been facilitated by
he development of reverse genetics, which has allowed
he elimination of V expression in MV (Schneider et al.,
997) and SeV (Kato et al., 1997b; Delenda et al., 1998)
with few or no observable effects on replication in vitro.
In vivo, SeVs devoid of V were markedly attenuated in the
lungs of mice compared to the wild type (Kato et al.,
1997b; Delenda et al., 1998). Further, recombinant SeVs
eleted of the unique cysteine-rich C-terminal portion of
have also been reported to replicate poorly in ICR
utbred mice (Kato et al., 1997a; Delenda et al., 1998).FIG. 1. Construction and generation of recombinant MVs lacking
expression of the C or V proteins. (A) Schematic diagram of the P cistron
encoding P, C, and V proteins showing alternative ORF for C and shared
P and V ORFs proximal to G insertion. Expression of the C protein was
eliminated by silencing of the C initiator AUG (met) by mutation of T to C
(bold), [p(1)MV position 1830] and placing a stop codon UAG (C to A
utation), [p(1)MV position 1845] downstream in the C ORF. Insertion of
he nontemplated G was eliminated by replacing A with G [p(1)MV
osition 2494], disrupting the cis-acting element (box) required for RNA
diting and generating a mutant MV lacking the expression of V. (B)Humans are the only natural host for MV, which, in
ddition to targeting the respiratory tract, regularly at-FIG. 2. Replication and spread of MV Ed, MV C2, and MV V2 in neuronal cells in vitro. (A) Two-step growth analysis of the three viruses in human
neuroblastoma SK-N-MC cells. At least three different experiments were performed for each virus with SK-N-MC cells. Infected at m.o.i. of 0.1. One,
2, and 3 days later, cells were harvested, freeze thawed at 280°C and titered on Vero cells by plaque assay. (B) Primary neurons were taken from
fetal (P16) YAC-CD46 transgenic mice (Rall et al., 1997) and infected with MV Ed, MV C2, and MV V2 (m.o.i. of 3). Seven days later coverslips were
stained with human antisera to MV. The number of infected neurons and spread of the viruses were similar for all three viruses.
FIG. 3. Mortality profiles and analysis of viral replication and spread in the brains of YAC-CD46 transgenic mice. (A) Percent mortality caused by
the three viruses at differing log dilutions of MV inoculation. Numbers at the end of each bar refer to the number of inoculated mice dead by Day 30
over the total number of mice inoculated per experimental group. (B) Comparison of the replication and spread of MV Ed, MV C2, and MV V2 in the
brains of YAC-CD46 transgenic mice inoculated with 1 3 104 PFU of the three different viruses. Cartoons display typical results obtained by comparing
spread of MV Ed to that of MV V2 and MV C2 in which the expression of the V or C proteins have been eliminated in brains of YAC-CD46 transgenic
mice 5–10 days after inoculation. The information shown is from four mice in each group. Similar differences in spread of virus were noted in
YAC-CD46 transgenic mice receiving 105 PFU. The lower panels show replication and tracking of MV and the mutants throughout neurons and axon
tracts in the cerebral cortex of YAC-CD46 brains as illustrated in the cartoons. Tissues were harvested 6–7 days after viral inoculation, fixed with 4%
paraformaldehyde, and sectioned in a vibratome, and 40-mm sections stained for the expression of MV antigens using polyclonal human antibody
to MV. Axon tracts of the extra pyramidal system are shown in panels 7–9, whereas those of the corticospinal pyrmidal tract are shown in 10–12.
Panels 2, 5, 8, and 11 are from a MV V2 inoculated mouse with the heaviest viral replication in neurons seen in panel 2 but little spread in axon tracts
(panels 5, 8, and 11). Only occasional neurons and axons throughout the CNS expressed viral antigens (panels 5 and 11). Arrows point to neurons
expressing viral antigens (panels 5 and 11). Similar patterns of low level viral expression and lack of axonal spread were seen in three other YAC-CD46
transgenic mice inoculated with MV V2 (104 PFU) and in two additional transgenic mice inoculated with 10-fold more MV V2 (105 PFU). By
comparison, panels 1, 4, 7, and 10 show commonly observed virus replication and spread at corresponding sites with MV Ed inoculated mice. This
pattern of MV replication and spread was uniformly observed in four additional mice inoculated with 103 and 104 PFU of virus. MV Ed and MV C2
4) in three mice inoculated with 10 PFU and two mice inoculated with
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84 PATTERSON ET AL.tacks the immune and occasionally the nervous systems.
Infection of the immune system causes a transient im-
mune suppression that can lead to severe complica-
tions. Infection of the central nervous system (CNS) can
induce an acute encephalopathology or rarely a chronic
CNS disease, subacute sclerosing panencephalitis
(SSPE), that ultimately results in death.
To study the pathogenesis of MV, we developed a
transgenic mouse model in which expression of the
MV receptor, CD46, largely mimics its natural expres-
sion in humans. These mice are highly susceptible to
CNS infection with the standard laboratory strain of
MV, Edmonston (Ed) (Oldstone et al., 1999). By using a
everse genetics system for MV (Radecke and Billeter,
996), we are now able to analyze host and viral genes
ontributing to replication, spread, and pathogenesis
f MV in vivo.
From these experiments, we have learned recombi-
ant MVs lacking expression of the C (MV C2) or V (MV
2) protein replicate equivalently to the parental vaccine
d strain in vitro but display markedly different replica-
ion and mortality profiles in vivo; both MV C2 and MV
2 kill far fewer mice relative to MV Ed at equivalent
oses. In vivo, MV V2 undergoes limited transcription
and replication and fails to spread within the CNS,
whereas MV C2 replicates and spreads as well as MV
Ed. These studies show that both C and V are required
for MV CNS pathogenesis but suggest the pathogenetic
activity is functionally distinct.
RESULTS
In vitro growth kinetics
Previous reports indicated that both MV C2 and MV
V2 had similar growth characteristics in cell culture
relative to the parental strain MV Ed (tag) (Radecke and
Billeter, 1996; Schneider et al., 1997). To extend these
findings to neuronal cells and analyze the growth char-
acteristics of these viruses, such mutants (Fig. 1) were
used to infect human neuroblastoma SK-N-MC cells.
Multistep growth analysis showed identical rates of rep-
lication for MV C2, MV V2, and MV Ed (Fig. 2A). The
CPE was similar for all three viruses. Growth rates in
HeLa cells were also similar for all these viruses al-
though peak titers reached 1 log higher than the neuro-
blastoma cells (data not shown). After infection of pri-
mary mouse CD461 neurons (Fig. 2B), replication and
spread were similar for all three viruses. Infection of
CD46 minus (CD462) mouse neurons did not support
infection (data not shown) (Rall et al., 1997). Culture
supernatants from infected CD461 mouse neurons did
not contain infectious virus; however, when such infected
neurons were cocultivated with Vero cells, the three
viruses formed similar numbers of plaques 7 days later. iMortality rates
To assess the mortality profiles for MV Ed, MV C2 and
MV V2, viruses were injected IC into 1-day-old CD461
mice, and mortality was quantitated. When injected with
as little as 103 PFU MV Ed, most mice died by Day 15
Oldstone et al., 1999) (Fig. 3A), yet none or 27% of the
ice injected with 103 PFU of MV V2 or MV C2, respec-
tively, died. Thirteen percent (4/32) of CD461 mice died
from 104 PFU of MV V2, and 48% (15/31) died from
infection with MV C2 compared to 90% mortality with the
MV Ed control (Fig. 3A). Increasing the dosage to 105
PFU resulted in death of 17 of 21 CD461 mice receiving
MV V2 comparable to the killing of the control virus.
When mice received 105 PFU of MV C2, only 7 of 16
44%) of the mice died.
iral spread in the CNS
To determine the extent of CNS infection by MV V2,
V C2, and MV Ed, the infected mouse brains were
tained for MV antigen with a monospecific antibody to
easles virus. Immunohistochemistry of brain sections
rom MV V2, MV C2, or MV Ed infected YAC-CD46 mice
–7 days p.i. showed significant differences between the
hree viruses. MV Ed and MV C2 revealed similar stain-
ng patterns throughout several regions of the brain
hen corresponding neuronal tracts and foci were as-
essed for at least five animals of each virally treated
roup (Fig. 3B). In comparison, MV V2 infected brains (5
f 5 mice) showed greatly reduced numbers of foci and
euronal tracts throughout (Fig. 3B), although the inten-
ity of staining in a few infected foci resembled that from
V Ed and C2 (Fig. 3B).
iral load and replication in the CNS
Because the spread of MV V2 was greatly reduced
ompared to MV Ed when analyzed by immunohisto-
hemistry, we sought to quantify the total viral load in the
rain of these animals. Viral RNAs from infected YAC-
D46 mouse brains were then analyzed by Northern blot.
V Ed and MV C2 had similar steady-state levels and
iming of viral transcripts whereas MV V2 yielded lower
evels at later times. Within 2 days p.i., MV N transcripts
ere comparable if not more abundant in three mice
noculated with MV V2 when compared to three mice
noculated with MV Ed (Fig. 4). Massive increase of viral
oad was noted by Day 10 for MV Ed when compared to
ay 2. Upon analysis of total viral transcripts, the relative
bundances of P, M, H, and F mRNAs were similar
mong individual mice; however, at Days 5 and 10 p.i.,
he total viral RNA for MV Ed and MV C2 was equivalent
ut was significantly reduced for MV V2 (Fig. 4).
nflammatory cytokines and chemokinesPreviously, we described cytokine and chemokine
nduction, apoptosis, activation of microglia, astrocy-
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85MEASLES VIRUS PROTEINS AS VIRULENCE FACTORS IN VIVOtosis, and lymphocyte infiltration following infection of
CD461 mice with MV Ed (Manchester et al., 1999;
ldstone et al., 1999). To understand the underlying
echanisms responsible for the differences in the
ortality and spread of MV Ed, MV V2, and MV C2,
e analyzed these markers of CNS pathogenesis by
Nase protection assay (RPA). Similar upregulation
as observed for the inflammatory cytokines IL-12,
T-b, TNF-a, IL-1a, IL-1b, and TGF-b and the IL-1
receptor between Days 5 and 10 p.i. (Fig. 5). No IFN-b
or g was detectable. The chemokines RANTES, MIP-
a, MIP-1b, MCP-1, IP-10, and TCA-3 were upregulated
n three brains each infected with MV Ed, MV V2, or
V C2 (Fig. 5). However, MV C2 infected brains
howed less RANTES expression relative to MV Ed
nd MV V2 infected brains. RPAs showed that steady-
FIG. 4. Replication and transcription of MV Ed, MV V2, and MV C2
blots are arranged so that viral load and transcription can be compared
(A) Northern blot analysis of total RNA (5 mg per lane) isolated from th
with MV N gene (top) showing comparable levels of N transcript at Da
N transcript by Day 10 of MV Ed infection. Cyclophilin was used as a p
of MV transcripts 5 days p.i. between three mice infected with MV Ed or
gel blot (5 mg total RNA per lane) was probed with entire MV genome, p
cyclophilin (bottom). (C) Northern gel blot showing reduced levels of M
relative to two mice infected with MV Ed at Day 10 p.i. (D) Comparison
C2. Transcript levels were similar if not greater in brains of three mic
5 or 10 days p.i. Northern blots were first probed with MV N gene (1.7 k
MV genome p(1) MV deleted of the N gene (top).tate levels of F4/80 mRNA were at least fivefold
igher for all mice infected with any of the threeiruses than those of uninfected YAC-CD46 mice.
UNEL staining, assaying for apoptosis, showed that
he numbers of apototic neurons were similar in brains
nfected with C2 and Ed viruses (data not shown).
Because SeV V2 and MV V2 had an attenuated phe-
otype in vivo, it could be that the V protein may modu-
ate the IFN system (Kato et al., 1997b). We thus com-
ared the type I IFN sensitivity of MV Ed and MV V2. No
ifferences were found even with concentrations of 1000
U on HeLa cells infected at m.o.i. of 0.1. Titers reached
02 and 103 PFU/ml after 24 h of infection and 2 3 105 to
13 106 PFU/ml after 48 h when cells were pretreated
with 1000 IU type I IFN.
Viral clearance or persistence
CNS of YAC-CD46 transgenic mice inoculated with 104 PFU. Northern
hree viruses in each individual mouse (number at bottom of each lane).
s of three mice each infected with MV Ed or MV V2. Blot was probed
he brain of MV Ed or MV V2 infected mice and massive expansion of
owing equal loading of the gel (bottom).(B) Comparison of the amount
showed greatly reduced levels of MV transcripts for MV V2. Northern
V (Radecke et al., 1995), excluding the N gene (top), and reprobed with
cripts (M, P, H, and F) in the brains of three mice infected with MV V2
NAs from N, M, P, H, and F genes of mice infected with MV Ed or MV
ed with MV C2 at Day 5 p.i. compared to brains infected with MV Ed
dle) and clyclophilin (1.0 kb) (bottom), stripped, and then repobed within the
for all t
e brain
y 2 in t
robe sh
MV V2
(1) M
V trans
of mR
e infectThe majority of YAC-CD46 1 mice infected with 1 3
104 PFU of MV V2 or MV C2 survived, whereas nearly
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86 PATTERSON ET AL.all mice similarly infected with MV Ed died. To determine
whether MV V2 or MV C2 persisted or were cleared in
surviving mice, we assessed the amount of viral RNA in
brains of four mice infected with MV C2 or MV V2. In
Fig. 6 we compared the viral load of one mouse infected
with MV Ed 10 days after infection with that in MV V2 or
MV C2 infected mice $30 days after infection. The brain
of only one MV V2 infected mouse contained significant
levels of MV N mRNA, and no N mRNA was detectable in
the MV C2 infected mice. When the same brains were
analyzed by RT–PCR for MV RNA, three of four MV V2
infected mice had detectable levels of MV RNA and two
of four MV C2 brains contained detectable viral levels.
DISCUSSION
Herein we report that the C and V proteins of MV
unction as virulence factors in a transgenic mouse
odel of MV induced CNS disease. MV V2 replicated
nd spread less efficiently than the parental virus MV Ed,
FIG. 5. RNase protection assays of cytokines and chemokines ex-
pressed in the brains of YAC-CD46 mice following inoculation with MV
Ed, MV C2 and MV V2. RPA analysis of specified cytokine or IL-1
receptor (IL-1R) from the brains of three mice each infected with 104
PFU of either MV Ed, MV C2 or MV V2 or uninfected YAC-CD46 control
mice (uninifected) from total brain RNA harvested 6–8 days p.i. (B) is
shown separately from (A) because relative expression levels were
much higher for LT-b, TNF-a, and TGF-b. (C) RPA analysis of relative
chemokine mRNA levels in the brains of the same mice analyzed for
cytokines in the above panels. Bars represent the mean normalized
values 6 standard error of specified cytokine or chemokine mRNA
species to housekeeping gene mRNAs L32 and GAPDH. 32P-labeled
protected RNA fragments were quantified using a molecular dynamics
phoshor screen, and storm 860 phosphorimager.esulting in a lower mortality rate for the V2 recipients.
owever, in the case of MV C2, replication and spread
i
cppeared similar to that of MV Ed, although MV C2
aused a lower mortality rate. This outcome suggests
ovel and disparate functions for the C and V proteins of
V.
Previously, C and V proteins of Paramyxoviruses were
hought to play a role in viral transcription and replication
Lamb and Kolakofsky, 1996). Although no function has
een established for the MV C protein, the SeV C protein
as been shown to have an inhibitory effect on viral
ranscription in vitro by a promoter-specific mechanism
Cadd et al., 1996; Tapparel et al., 1997). The C proteins
f Morbilliviruses and other Paramyxoviruses are related
y gene position but not by sequence (21% aa identity
etween MV C and SeV C proteins), yet they are all basic
nd relatively small (180–209 aa). It is possible that the
unctions of MV C and SeV C are not or only partially
onserved. Using reverse genetics, C proteins have
een silenced for both MV and SeV, and the MV C2
ecovered had no observable defects in vitro, while the
eplication of SeV C2 was greatly restricted. This dem-
nstrated that although C and the related C9, Y1 and Y2,
roteins are not absolutely required for replication, they
re important for efficiency of replication and pathogen-
sis (Kurotani et al., 1998).
Previous reports have stated that MV C2 grew rela-
ively poorly in human PBMC in vitro (Escoffier et al.,
999) and reached lower peak titers in vivo in mice
eceiving human thymic xenografts (Valsamakis et al.,
998). In contrast to these reports, we have shown that
V C2 replicated and spread similarly to MV Ed in the
NS of YAC-CD46 transgenic mice; however, the mortal-
ty due to MV C2 was greatly reduced. A possible ex-
lanation for this discrepancy is that in our studies rep-
ication was studied in the CNS, whereas the others
FIG. 6. Analysis of viral clearance or persistence in the brains of
YAC-CD46 mice 30 days p.i. Mice were infected with 104 PFU MV C2
r MV V2 and killed 30 days later. Northern analysis of four mice from
ach group showed only minimal amounts of N transcript in one mouse
nfected with MV V2 (lane 6) compared to heavy viral load of MV Ed
104 PFU) infected mouse at Day 10 (lane 2). RT–PCR analysis of the
ame brains with MV N gene specific primers showed amounts of N
ranscript in the other mice infected with MV V2 (lanes 4 and 5) or MV
2 (lanes 9 and 10) and no detectable N transcript in one mousenfected with MV V2 (lane 3) and two infected with MV C2 after 40
ycles of amplification.
rd
t
s
m
a
m
b
w
r
i
c
r
r
I
m
i
I
C
k
w
m
t
d
c
s
t
c
t
A
s
e
b
1
i
l
C
h
w
i
d
C
s
C
87MEASLES VIRUS PROTEINS AS VIRULENCE FACTORS IN VIVOinfected cells of the immune system in vitro (Escoffier et
al., 1999) or in mice lacking an immune system (Valsa-
makis et al., 1998). Investigation of markers for CNS
pathology demonstrated that inflammatory cytokines
such as TNF-a, which has been described as mediators
of neuronal cell death (Campbell et al., 1998), were up-
egulated in MV Ed, MV V2, and MV C2 infected brains.
Mice receiving 103 or 104 PFU of MV C2, typically did not
ie and eventually cleared or greatly reduced viral con-
ent. Because MV Ed and MV C2 infected mice had
imilar viral loads, extents of spread, and cytokine/che-
okine profiles, the reason for differences in mortality
re not yet clear. Preliminary analysis of lymphocyte
arkers by RPA showed higher levels of TCRd, TCRa,
CD3e, CD4, CD8a, CD8b, F4/80, and CD45 for three
rains infected with MV C2 compared to those infected
ith MV Ed or MV V2 at Day 5 p.i., suggesting a possible
ole for the innate or adaptive immune response in lim-
ting MV infection in the absence of C. This possibility is
urrently under investigation.
In the case of MV V2 pathogenesis, mortality was
elated to viral load and spread, and both were greatly
educed for MV V2 compared to the parental MV Ed.
nterestingly, cytokine, chemokine and lymphocyte
arkers were at equivalent levels for MV V2 and MV
Ed, even though at 5 and 10 days after infection, the
viral load was greatly reduced in MV V2 infected mice.
Although the MV V protein is clearly not required for
regulation of transcription or replication in some cell
types (Schneider et al., 1997), the V protein may control
those processes in other cells. (Tober et al., 1998;
Valsamakis et al., 1998).
Our work is in agreement with studies in other
models of MV and SeV pathogenesis whereby deletion
of V attenuates pathogenesis. That is, MV V2 grew
more slowly than wild type in the lungs of cotton rats
(Tober et al., 1998) and in human thymuses implanted
into SCID mice where the incidence of thymocyte
apoptosis decreased (Valsamakis et al., 1998). Simi-
larly, a SeV V2 mutant was hampered in the ability to
replicate and to cause pathogenesis in the lungs of
mice; this mutant replicated for 1 day and was cleared
by Day 9, whereas the wild-type SeV killed all infected
mice by Day 9 (Kato et al., 1997b). We also found that
MV V2 and MV Ed had a similar viral load at Day 2, but
after Day 5, the quantity of MV V2 was markedly
reduced compared to MV Ed.
Many viruses interfere with the IFN system, and Kato
et al., (1997b) suggested such a scenario for SeV V
protein. However, treatment of HeLa cells with 1000 IU of
IFN showed no difference in IFN sensitivity between MV
Ed or MV V2. Similarly, no differences in type I IFN
production followed MV Ed and MV V2 infection of
human PBMC (D. Naniche et al., unpublished observa-
tions). Therefore abrogation of the IFN system probably
does not play a role in the greater spread of MV Ed as
m
icompared to MV V2. In the case of SeV, reports have
shown that C protein rather than V protein (Garcin et al.,
1999) is responsible for inhibition of IFN-induced antiviral
effects (Didcock et al., 1999).
Surprisingly, little if any IFN-g was detected during the
mmune response to any of the MVs, and induction of
FN-b was not observed. Our preliminary data from YAC-
D46 mice crossed with type I IFN receptor- or IFN-g-
nock-out mice suggest that type I IFNs are protective,
hereas IFN-g plays little if any role (Patterson et al.,
anuscript in preparation). Conceivably, at least one of
he numerous IFN-as are being produced in vivo.
Because of the lack of IFN-g induction or protection of
MV-infected YAC-CD46 mice, an interesting question that
arises from this study is how are MV C2 and MV V2
cleared from the CNS because CD81 T cells are unable
to recognize and directly kill virus infected neurons due
to lack of MHC class I expression (Joly et al., 1991) Mice
that cannot produce B or T cells are much more suscep-
tible to CNS infection by MV (Lawrence et al., 1999),
indicating that adaptive immunity may be responsible for
protection of neurons from MV infection; however, the
mechanism of clearance remains to be established.
Our studies clearly demonstrate that MV V and C
proteins operate by different mechanisms in vivo and
suggest the involvement of an interaction with host fac-
tors that may be in part neuron specific, as neurons
constitute 99% of MV infected cells in the CNS of YAC-
CD46 mice (Oldstone et al., 1999). The V protein of
simian virus 5 and MV interact with the damage specific
DNA binding protein, DDB, (Lin et al., 1998); however, it is
ifficult to explain how such an interaction would ac-
ount for the differences we observe in mortality and
pread in the developing CNS. Nonstructural viral pro-
eins could conceivably interact with one or more host
omponents because many such viral proteins have mul-
iple physiological functions. For example, the influenza
NS1 protein is thought to be involved with pre-mRNA
plicing, retention of polyA (1) RNA within the nucleus,
nhanced viral mRNA translation (Ortin, 1998) and inhi-
ition of the antiviral action of IFN (Garcia-Sastre et al.,
998). These functions are likely mediated by NS1 bind-
ng to RNA (Wang et al., 1999) and interacting with at
east four unique cellular proteins (Tan and Katz, 1998;
hen et al., 1999; Marion et al., 1999). All animal viruses
ave been selected for replication and spread in the
hole organism that they infect. To do so, they must
nfect multiple cell types and deal with a vigorous and
iverse immune response. It is entirely possible that both
and V have numerous functions, both tissue and cell
pecific in their natural host. A better understanding of
NS infection and immune suppression by MV in hu-
ans likely rests on determining the host cellular factors
nvolved.
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Viruses and cells
MV Ed (tag), MV C2, and MV V2 were generated
using the MV reverse genetics system as described in
Fig. 1 (Radecke et al., 1995; Radecke and Billeter, 1996;
chneider et al., 1997), amplified, and passaged in Vero
ells. Virus stocks were prepared by low-multiplicity in-
ection of Vero cells, harvested as supernatants after
ow-speed centrifugation to remove cellular debris and
tored at 270°C. Each stock was retitered on Vero cells.
creening of transgenic mice
YAC-CD46 transgenic mice were screened by tail bi-
psy and purification of genomic DNA, followed by dot–
lot hybridization with a 32P-labeled CD46 cDNA probe
as previously described (Oldstone et al., 1999). YAC-
CD46 mice were maintained by mating them with FVB/N
mice obtained from the Scripps Rodent Breeding Colony.
Infection of mice with recombinant MVs
FVB/N mice heterozygous for the YAC-CD46 transgene
were bred to nontransgenic FVB/N, and the offspring of
these matings were infected with the different recombi-
nant MVs intracranially (IC). At least 30 one-day-old mice
were inoculated IC with each virus (MV Ed tag, MV C2
and V2) with 1 3 103, 1 3 104, or 1 3 105 PFU. Cages
were monitored daily; deaths were recorded, and tails
were taken for confirmation of the CD46 transgene.
Immunohistochemistry
Brains were harvested from mice at various times
postinfection, fixed with 4% paraformaldehadye, and cut
into 40-mm sections in a vibratome. Sections were
locked with normal goat serum, biotin, and streptavidin
Vector Laboratories, Burlingame, CA). Immunostaining
as performed with the Vectastain Elite kit (Vector Lab-
ratories) as described (Rall et al., 1997; Oldstone et al.,
999). Anti-MV antibody was a human polyclonal anti-
erum from an SSPE patient and was previously shown
o recognize MV antigens (Manchester et al., 1999; Old-
tone et al., 1999).
orthern blot analysis of MV replication
At the time of death, brains were removed from the
ice and divided along the midline. One hemisphere
as immediately frozen in liquid nitrogen, whereas the
ther half was frozen in OCT compound on dry ice for
reparing cryostat sections. RNA was isolated from
resh-frozen brains using Tri-reagent (Molecular Re-
earch Center, Cincinnati, OH). Total RNA (5 mg/sample)
as run on a 1.5% formaldehyde-agarose gel and trans-erred to a Nytran membrane (Micron Separations, West-
orough, MA). For detection of MV mRNA, a MV2Nrobe was prepared by random primer labeling the
.7-kb cDNA fragment from the MV N-gene (plasmid
eN1). Blots were probed with a random-primed, 32P-
radiolabeled DNA probe for MV nucleoprotein RNA or
the entire genomic cDNA for MV, p(1)MV, deleted of N
(Radecke et al., 1995) by hybridizing at 65°C in Quick-
Hyb (Stratagene, La Jolla, CA) for 3 h. Blots were washed
at high a stringency with 0.23 SSC/0.1% SDS at 65°C
Quantitation of cytokines and chemokines by RNase
protection assay
Measurement of steady-state levels of cytokine and
chemokine mRNAs was performed using the Riboquant
RPA assay system according to the manufacturer’s in-
structions (Pharmingen, La Jolla, CA). Total RNA (20 mg/
sample) was used. 32P-labeled probe sets were prepared
and hybridized to the total brain RNA overnight. Follow-
ing RNase digestion of hybridized RNAs, samples were
separated on an 8% polyacrylamide gel, dried for 1 h, and
exposed to a phosphorimager screen (Molecular Dy-
namics Systems, Sunnyvale, CA). L32 and GAPDH stan-
dards were included in each lane. The Pharmingen
probe sets mCK-2 and mCK-3b were used for cytokine
analysis, probe set mCK-5 was used for chemokine anal-
ysis.
RT–PCR analysis of MV persistence
RT–PCR amplification of MV RNA was carried out
using MV N gene specific primers 59-GGCCACACTTTTA-
AGGAGCTTAGC-39 and 59-GGGCCGTAACCGCCTTT-
GCG-39, 59, and 39 relative to the N mRNA, respectively.
The 553 nt N fragment was generated using standard
conditions with Taq polymerase (Boehringer Mannheim,
Germany) and 40 cycles of amplification
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